Athersys Inc - Company Profile
Powered by 
All the data and insights you need on Athersys Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Athersys Inc Strategy Report
- Understand Athersys Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary therapies in the field of regenerative medicine. It is investigating its lead platform, MultiStem, a patented stem cell product for treating chronic conditions such as cardiovascular diseases, inflammatory and immune disorders, neurological, and pulmonary disorders. The company’s MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, traumatic brain injury, vascular disease, acute pulmonary distress, wound healing, organ reperfusion, bone marrow/hematopoietic stem cell transplantation, ischemic stroke, and autoimmune disease. The company's pipeline consists of therapeutic product development programs in multiple disease areas, through the application of proprietary technologies. Athersys is headquartered in Cleveland, Ohio, the US.
Headquarters
United States of America
Address
3201 Carnegie Ave, Cleveland, Ohio, 44115-2634
Telephone
1 216 4319900
No of Employees
24
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ATHXQ (OTC)
Revenue (2021)
$5.3M
-3.4%
(2021 vs 2020)
EPS
XYZ
Net Income (2021)
XYZ
16.6%
(2021 vs 2020)
Market Cap*
$270,000
Net Profit Margin (2021)
XYZ
13.6%
(2021 vs 2020)
* As of and is in US$
Athersys Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| MultiStem |
Competitor Comparison
| Key Parameters | Athersys Inc | Pfizer Inc | Vericel Corp | Cryo-Cell International Inc | Plus Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Cleveland | New York | Cambridge | Oldsmar | Austin |
| State/Province | Ohio | New York | Massachusetts | Florida | Texas |
| No. of Employees | 24 | 88,000 | 314 | 82 | 20 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jane Wasman | Chairman | Executive Board | 2023 | 66 |
| Daniel A. Camardo | Chief Executive Officer; Director | Executive Board | 2022 | 53 |
| Maia Hansen | Chief Operating Officer | Senior Management | 2022 | - |
| Kasey Rosado | Chief Financial Officer - Interim | Senior Management | 2022 | - |
| James Glover | Executive Vice President; Head - Manufacturing | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer